Bayer to Present New Phase III Data from Its Cardiovascular, Kidney, and Stroke Clinical Trial Programs at ESC 2026
Go back to Bayer to Present New Phase III Data from Its Cardiovascular, Kidney, and Stroke Clinical Trial Programs at ESC 2026| Bay National Corporation (AMEX: BAYN) | Delayed: 0.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.01 | 52 Week High | $0.04 | |||
| Open | $61.11 | 52 Week Low | $0.03 | |||
| Day High | $0.01 | P/E | 0.00 | |||
| Day Low | $0.01 | EPS | $-8.34 | |||
| Volume | 358,028 | |||||
| Bay National Corporation (AMEX: BAYN) | Delayed: 0.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.01 | 52 Week High | $0.04 | |||
| Open | $61.11 | 52 Week Low | $0.03 | |||
| Day High | $0.01 | P/E | 0.00 | |||
| Day Low | $0.01 | EPS | $-8.34 | |||
| Volume | 358,028 | |||||
| Bayer Aktiengesellschaft American Depositary Shares (AMEX: BAYRY) | Delayed: 14.13 +0.08 (0.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.05 | 52 Week High | $135.54 | |||
| Open | $14.14 | 52 Week Low | $94.36 | |||
| Day High | $14.19 | P/E | N/A | |||
| Day Low | $14.05 | EPS | $0.00 | |||
| Volume | 328,544 | |||||
| Bayer AG (AMEX: BAYZF) | Delayed: 56.38 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $56.38 | 52 Week High | $135.00 | |||
| Open | $56.38 | 52 Week Low | $94.95 | |||
| Day High | $56.38 | P/E | N/A | |||
| Day Low | $56.38 | EPS | $0.00 | |||
| Volume | 21 | |||||

